VERA Cash-Secured Put Strategy

VERA (Vera Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Vera Therapeutics, Inc. is a clinical-stage biotechnology company focused on the development and commercialization of treatments for significant immunological disorders, primarily within the United States. Their leading therapeutic candidate is atacicept, a fusion protein that patients self-administer as a subcutaneous injection. This drug is currently undergoing Phase IIb clinical trials to treat immunoglobulin A nephropathy. The company is also advancing MAU868, a monoclonal antibody in Phase 2 clinical development, designed to combat BK viremia infections. Founded in 2016 and based in Brisbane, California, the organization operated as Trucode Gene Repair, Inc. until it rebranded to Vera Therapeutics, Inc. in April 2020.

VERA (Vera Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $3.05B, a beta of 0.95 versus the broader market, a 52-week range of 19.066-56.05, average daily share volume of 1.2M, a public-listing history dating back to 2021, approximately 152 full-time employees. These structural characteristics shape how VERA stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.95 places VERA roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.

What is a cash-secured put on VERA?

A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike.

Current VERA snapshot

As of June 30, 2026, spot at $43.48, ATM IV 161.00%, IV rank 35.03%, expected move 46.16%. The cash-secured put on VERA below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.

Why this cash-secured put structure on VERA specifically: VERA IV at 161.00% is mid-range versus its 1-year history, so the credit collected on a VERA cash-secured put sits in line with its long-run distribution, with a market-implied 1-standard-deviation move of approximately 46.16% (roughly $20.07 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated VERA expiries trade a higher absolute premium for lower per-day decay. Position sizing on VERA should anchor to the underlying notional of $43.48 per share and to the trader's directional view on VERA stock.

VERA cash-secured put setup

The VERA cash-secured put below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With VERA near $43.48, the first option leg uses a $41.31 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed VERA chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 VERA shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Sell 1Put$41.31N/A

VERA cash-secured put risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium.

VERA cash-secured put payoff curve

Modeled P&L at expiration across a range of underlying prices for the cash-secured put on VERA. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use cash-secured put on VERA

Cash-secured puts on VERA earn premium while a trader waits to acquire VERA stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning VERA.

VERA thesis for this cash-secured put

The market-implied 1-standard-deviation range for VERA extends from approximately $23.41 on the downside to $63.55 on the upside. A VERA cash-secured put lets a trader earn premium while waiting to acquire VERA at the strike price; the strategy is most attractive when the trader is comfortable holding the underlying at that level and IV is rich enough to compensate for the assignment risk. Current VERA IV rank near 35.03% is mid-range against its 1-year distribution, so the IV signal is neutral; the cash-secured put thesis on VERA should anchor more to the directional view and the expected-move geometry. As a Healthcare name, VERA options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to VERA-specific events.

VERA cash-secured put positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. VERA positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move VERA alongside the broader basket even when VERA-specific fundamentals are unchanged. Short-premium structures like a cash-secured put on VERA carry tail risk when realized volatility exceeds the implied move; review historical VERA earnings reactions and macro stress periods before sizing. Always rebuild the position from current VERA chain quotes before placing a trade.

Frequently asked questions

What is a cash-secured put on VERA?
A cash-secured put on VERA is the cash-secured put strategy applied to VERA (stock). The strategy is structurally neutral to slightly bullish: A cash-secured put sells an out-of-the-money put while holding cash equal to the strike-times-100 obligation, keeping the premium when the underlying stays above the strike. With VERA stock trading near $43.48, the strikes shown on this page are snapped to the nearest listed VERA chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are VERA cash-secured put max profit and max loss calculated?
Max profit equals premium times 100; max loss equals strike minus premium times 100 (at zero, assuming assignment). Breakeven is strike minus premium. For the VERA cash-secured put priced from the end-of-day chain at a 30-day expiry (ATM IV 161.00%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a VERA cash-secured put?
The breakeven for the VERA cash-secured put priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current VERA market-implied 1-standard-deviation expected move is approximately 46.16%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a cash-secured put on VERA?
Cash-secured puts on VERA earn premium while a trader waits to acquire VERA stock at a target strike below the current quote; most attractive when IV is rich and the trader is comfortable owning VERA.
How does current VERA implied volatility affect this cash-secured put?
VERA ATM IV is at 161.00% with IV rank near 35.03%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

Related VERA analysis